Below is the current list of studies covered by the CIRB. It includes both Available to Open and Completed studies. Study documents approved after July 1, 2013 for all covered studies are available on the CTSU website.
To request documents approved before July 1, 2013, please contact the CIRB Helpdesk.
|Study Number||Lead Group||Study Title||CIRB||Study Status|
|UAZ21-07-01||CP-CTNet_CLO-University of Arizona||M4OC-Prevent 2.0: Phase IIb Trial of Metformin for Oral Cancer Prevention||Cancer Prevention and Control CIRB||Available to Open|
|UAZ21-06-01||CP-CTNet_CLO-University of Arizona||Phase II Randomized, Double Blind, Placebo-Controlled Trial of the Broccoli Seed and Sprout Extract (BSSE), Avmacol ES, to Evaluate Sustained Detoxification of Tobacco Carcinogens in Heavy Smokers||Cancer Prevention and Control CIRB||Available to Open|
|UAZ2017-09-02||CP-CTNet_CLO-University of Arizona||Clinical Study of Avmacol® for Detoxification of Tobacco Carcinogens in Heavy Smokers||Cancer Prevention and Control CIRB||Completed|
|UAZ2016-08-02||CP-CTNet_CLO-University of Arizona||A feasibility trial of alternating intravaginal application of 5-fluorouracil and imiquimod for treatment of high-grade cervical squamous intraepithelial lesions||Cancer Prevention and Control CIRB||Available to Open|
|UAZ2015-05-02||CP-CTNet_CLO-University of Arizona||M4OC-Prevent: Metformin for Oral Cancer Prevention||Cancer Prevention and Control CIRB||Completed|
|UAZ2015-05-01||CP-CTNet_CLO-University of Arizona||A prospective, single-arm, open-label, non-randomized, phase IIA trial of a nonavalent prophylactic HPV vaccine to assess immunogenicity of a prime and deferred-booster dosing schedule among 9-11 year-old girls and boys||Cancer Prevention and Control CIRB||Available to Open|
|UAZ20-01-02||CP-CTNet_CLO-University of Arizona||An extended follow-up study of the HPV vaccine delayed booster trial||Cancer Prevention and Control CIRB||Available to Open|
|UAZ20-01-01||CP-CTNet_CLO-University of Arizona||Clinical Study of Bioactivity of Low Dose Apalutamide in Prostate Cancer Patients Scheduled for Prostatectomy||Cancer Prevention and Control CIRB||Available to Open|
|TRC-10446||NCI||Tocilizumab in Hospitalized Cancer Patients with Coronavirus 2019 (SARS-CoV-2) and Severe Complications of Coronavirus Disease 19 (COVID-19)||Adult CIRB - Late Phase Emphasis||Completed|
|SWOG-9007||SWOG||Cytogenetic Studies in Leukemia Patients||Adult CIRB - Late Phase Emphasis||Completed|